Last 16.55 INR
Change Today 0.00 / 0.00%
Volume 0.0
VIVO On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:00 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

vivo bio tech ltd (VIVO) Snapshot

Open
16.55
Previous Close
16.55
Day High
16.55
Day Low
16.55
52 Week High
07/10/14 - 17.40
52 Week Low
03/4/14 - 14.38
Market Cap
154.8M
Average Volume 10 Days
0.0
EPS TTM
0.31
Shares Outstanding
9.4M
EX-Date
12/4/95
P/E TM
53.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for VIVO BIO TECH LTD (VIVO)

Related News

No related news articles were found.

vivo bio tech ltd (VIVO) Related Businessweek News

No Related Businessweek News Found

vivo bio tech ltd (VIVO) Details

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical, biotech, and agri companies worldwide. The company offers services in the areas of in-vitro, in-vivo, toxicity studies, pharmacological investigations, and pharmacokinetic and toxicokinetic studies. Its biologic research services include molecular biology services, mutation screening by growth promotion tests, process development and scale-up of recombinant proteins, protein purification and characterization, cell based assay development, stability studies, raising polyclonal antibodies and purification, and method development and validation for biologics. The company offers in-vitro services and screening programs, such as AMES, micronucleus, chromosomal aberration, neutral red uptake, oxidative DNA damage, and SHE cell transformation assay, as well as various in-vitro ADME services to support drug development program. It also provides in-vivo services, including preclinical testing services in rodents/non-rodents, and canines for the evaluation of toxicity, pharmacological properties, and ADME and PK properties of drug candidates in early stage development process. In addition, Vivo Bio Tech Limited is involved in pathogen screening of various specimens; and in-house breeding of specific pathogen free rodents. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Secunderabad, India.

Founded in 1987

vivo bio tech ltd (VIVO) Top Compensated Officers

Chief Executive Office and Whole Time Directo...
Total Annual Compensation: 3.0M
Whole Time Director, Member of Audit Committe...
Total Annual Compensation: 183.7K
Test Facility Manager
Total Annual Compensation: 150.0K
Compensation as of Fiscal Year 2014.

vivo bio tech ltd (VIVO) Key Developments

Vivo Bio Tech Ltd. to Report Q3, 2015 Results on Feb 11, 2015

Vivo Bio Tech Ltd. announced that they will report Q3, 2015 results on Feb 11, 2015

Vivo Bio Tech Ltd., Board Meeting, Feb 11, 2015

Vivo Bio Tech Ltd., Board Meeting, Feb 11, 2015. Agenda: To consider the unaudited financial results for the third quarter ended December 31, 2014.

Vivo Bio Tech Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Vivo Bio Tech Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported total income from operations of INR 34.943 million compared to INR 35.790 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 0.459 million compared to INR 0.628 million a year ago. Profit from ordinary activities before tax was INR 1.329 million compared to INR 1.875 million a year ago. Net profit for the period was INR 1.063 million or INR 0.11 per basic and diluted share before and after extraordinary items compared to INR 1.665 million or INR 0.18 per basic and diluted share before and after extraordinary items a year ago. For the six months, the company reported total income from operations of INR 71.607 million compared to INR 39.551 million a year ago. Loss from operations before other income, finance cost and exceptional items was INR 2.086 million compared to profit from operations before other income, finance cost and exceptional items of INR 0.071 million a year ago. Profit from ordinary activities before tax was INR 0.019 million compared to INR 2.096 million a year ago. Net loss for the period was INR 0.246 million or INR 0.03 per basic and diluted share before and after extraordinary items compared to net profit for the period of INR 1.509 million or INR 0.16 per basic and diluted share before and after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIVO:IN 16.55 INR 0.00

VIVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Vimta Labs Ltd 60.15 INR -0.10
View Industry Companies
 

Industry Analysis

VIVO

Industry Average

Valuation VIVO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVO BIO TECH LTD, please visit www.vivobio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.